OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NERV

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Minerva Neurosciences (NERV) Earnings Date & Reports

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NERV is expected to report earnings to fall 18.60% to -34 cents per share on November 10

Minerva Neurosciences NERV Stock Earnings Reports

Q3'25

Est.

$-0.35

Q2'25

Beat

by $0.47

Q1'25

Beat

by $0.57

Q4'24

Missed

by $1.53

Q3'24

Beat

by $3.98

The last earnings report on August 14 showed earnings per share of -43 cents, beating the estimate of -89 cents. With 422.87K shares outstanding, the current market capitalization sits at 15.74M.

View a ticker or compare two or three

Compare

NERV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NERV
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NERV showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1500 District Avenue

Phone

+1 617 600-7373

Employees

Web

https://www.minervaneurosciences.com